KYODO NEWS IMAGELINK

報道写真の購入なら共同通信イメージリンク

お問い合わせ
03-6252-6224
平日9:30-18:00

「免疫疾患」の写真・グラフィックス・映像

絞り込み
  • 提供元
  • 日付
  • 種類
  • 向き
  • カテゴリ
並び順
  • 古い順
41
( 1 41 件を表示)
  • 1
41
( 1 41 件を表示)
絞り込み
並び順
  • 古い順
  •  Medication
    2021年07月10日
    Medication

    July 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット:©Karen Focht/ZUMA Wire/共同通信イメージズ

    商品コード: 2021071208729

  •  Medication
    2021年07月10日
    Medication

    July 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット:©Karen Focht/ZUMA Wire/共同通信イメージズ

    商品コード: 2021071208618

  •  Medication
    2021年07月10日
    Medication

    July 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット:©Karen Focht/ZUMA Wire/共同通信イメージズ

    商品コード: 2021071208332

  •  Systemic lupus erythematosus
    2021年08月12日
    Systemic lupus erythematosus

    Systemic lupus erythematosus (autoimmune disease) with inflammatory skin of the fingers.、クレジット:CAVALLINI JAMES / BSIP/Universal Images Group/共同通信イメージズ

    商品コード: 2022082511451

  •  Autoimmune Disorder
    2022年09月21日
    Autoimmune Disorder

    September 21, 2022, DUBUQUE, IOWA, USA: Carole Schmidt, left undergoes Intravenous immunoglobulin (IVIg) therapy for Immune thrombocytopenia (also known as ITP) at the MercyOne Cancer Center in Dubuque, Iowa. ITP is an autoimmune disorder causing internal bruising and an increased incidence of sometimes life-threatening internal bleeding. Bleeding occurs because the immune system attacks a certain type of cell - platelets - which are needed to help control bleeding. ITP is more common among young women and children. The risk appears to be higher in people who also have diseases such as rheumatoid arthritis, lupus and antiphospholipid syndrome. Research indicates ITP patients often have had a virus or viral infection about three weeks before developing ITP. Scientists believe that the body, when making antibodies against the virus, may have ‘‘accidentally‘‘ made an antibody that sticks to the platelet cells. The body then recognizes these platelet cells with antibodies as foreign cells and destroys them. Th...

    商品コード: 2022092703185

  •  Autoimmune Disorder
    2022年09月21日
    Autoimmune Disorder

    September 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット:©Kevin E. Schmidt/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2022092703152

  •  Autoimmune Disorder
    2022年09月21日
    Autoimmune Disorder

    September 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット:©Kevin E. Schmidt/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2022092703165

  •  Autoimmune Disorder
    2022年09月21日
    Autoimmune Disorder

    September 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット:©Kevin E. Schmidt/ZUMA Press Wire/共同通信イメージズ

    商品コード: 2022092703213

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 A man is seen at Pharmasyntez Nord plant before the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104352

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104701

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Director General of the Pharmasyntez Nord company Mikhail Kvasnikov, President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104703

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104702

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104927

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov attend he opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104925

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104926

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105852

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105857

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105849

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov and President of the Pharmasyntez group of companies Vikram Punia, visits the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Anton Vergun / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104931

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104929

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105839

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Anton Vergun / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040104932

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105666

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105835

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105848

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105851

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105836

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105847

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105845

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105838

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105850

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105846

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105841

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105840

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105837

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105844

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105843

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105842

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 St. Petersburg Governor Alexander Beglov attends the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105879

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov attends the opening ceremony Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105877

  •  Russia Pharmaceutical Industry Pharmasyntez Nord
    2023年03月30日
    Russia Pharmaceutical Industry Pharmasyntez Nord

    30.03.2023 A view shows the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット:Sputnik/共同通信イメージズ

    商品コード: 2023040105880

  • 1